Schulhoff & Co Inc
- SEC CIK
- 0001080197
- Latest filing
- Aug 13, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Schulhoff & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,856
- Value
- $258.4K
- % of portfolio
- 0.1%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,856 | $258.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 2,856 | $228.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,856 | $243.5K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,856 | $221.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,856 | $223.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,856 | $207.0K | 0.1% | +2,856 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −2,856−100.0% | Sold out | Holders |
| Q2 2024 | 2,856 | $263.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,856 | $272.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,856 | $217.8K | 0.1% | +2,856 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −2,856−100.0% | Sold out | Holders |
| Q2 2023 | 2,856 | $269.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,856 | $236.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,856 | $213.1K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,856 | $235.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,856 | $271.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,856 | $336.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,856 | $369.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,856 | $323.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,856 | $295.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 2,856 | $238.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.